July 6, 2006

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival. (Current Controlled Trials number, ISRCTN93793971 controlled-trials.com.).

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Cunningham et al. (Thu,) studied this question.

www.synapsesocial.com/papers/69d9b0f45e5bcb4e3b837acb — DOI: https://doi.org/10.1056/nejmoa055531

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial· 2004 · 199 citations
ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER· 1989 · 97 citations
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)· 1994 · 260 citations
Prognostic relevance of systemic lymph node dissection in gastric carcinoma· 1995 · 275 citations

Authors

David Cunningham

William Allum

Sally Stenning

Journals

New England Journal of Medicine

Actions

Institutions

Medical Research Council

Leiden University Medical Center

Southampton General Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion